Saitama Cancer Center
In research, Saitama Cancer Center stands highest in Medicine (#5,591 of 10,443 worldwide) and Health Sciences (#7,373 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Surgery — Oncology is 16.1× its share of world research.
- World rank, 2022–2025
- #19,166 of 28,054 · #11,345 all time
- Rank in Japan
- #535 of 1,070
- Research works
- 1.7k ▼ 6% vs 2013–17
- Citations
- 49k 29.1 per fractional work
- Top-10% rate
- 10.2% record average 16.5%
- Open access
- 39% world 28%
What is Saitama Cancer Center known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,591 of 10,443 | 10.2% | 134 | #5292 | |
| Health SciencesDomain | #7,373 of 11,982 | 10.1% | 136 | #7194 |
Each strip is that field’s whole ranked pool, with the notch where Saitama Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Saitama Cancer Center specialise in?
Where its research is concentrated relative to its size: Oncology takes 16.1× the share of its output that it takes of world research.
- OncologySubfield · 29.6 works16×
- Pulmonary and Respiratory MedicineSubfield · 25.3 works10×
- SurgerySubfield · 29.3 works7.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
- Medicine 4.3×
- Biochemistry, Genetics and Molecular Biology 2.3×
- Immunology and Microbiology 1.0×
- Dentistry 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Nursing 0.3×
- Physics and Astronomy 0.2×
- Neuroscience 0.2×
- Decision Sciences 0.2×
- Chemistry 0.2×
- Health Professions 0.1×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
- Computer Science 0.0×
- Social Sciences 0.0×
- Environmental Science 0.0×
- Materials Science 0.0×
Who are the top researchers at Saitama Cancer Center?
Ranked on the composite score, Kenichi Inoue, Hirota Fujiki and Motoo Hozumi lead among researchers whose main affiliation is Saitama Cancer Center.
- 1 Kenichi Inoue Japan · #66,386 worldwide 296 citations · 71 works
- 2 Hirota Fujiki Japan · #138,216 worldwide 307 citations · 62 works
- 3 Motoo Hozumi Japan · #213,915 worldwide 105 citations · 38 works
- 4 Yasuhiko Kaneko Japan · #248,056 worldwide 118 citations · 54 works
- 5 Hiroki Hara Japan · #287,541 worldwide 202 citations · 77 works
- 6 Hiroshi Sakai Japan · #293,117 worldwide 187 citations · 101 works
- 7 Yusaku Tagashira Japan · #385,883 worldwide 49 citations · 23 works
- 8 Nobuo Maseki Japan · #417,632 worldwide 124 citations · 15 works
- 9 Yusuke Nishizawa Japan · #437,751 worldwide 13 citations · 27 works
- 10 H Nishimura Japan · #544,117 worldwide 20 citations · 20 works
Which keywords describe research at Saitama Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Endoscopic Resection, Neoadjuvant Therapy, Clinical Practice Guidelines, Tumor Microenvironment, Prognostic Factors, Molecular Characterization and Survival Analysis.
- Prognostic Markers
- Molecular Subtypes
- PET Imaging
- Rituximab
- Metastasis
- Genetic Mutations
- Quality of Life
- PD-1 and PD-L1
- Metastatic Gastric Cancer
- Neoadjuvant Chemotherapy
- Targeted Therapy
- Barrett's Esophagus
- Surgery
- Radiotherapy
- Preoperative Chemoradiotherapy
- Immunotherapy
- Prognostic Factors
- Epidemiology
- Clinical Practice Guidelines
- Endoscopic Resection
- Chemotherapy
- Neoadjuvant Therapy
- Tumor Microenvironment
- Molecular Characterization
- Survival Analysis
- Chemoradiation
- Adjuvant Therapy
- Gastric Cancer
- Cancer
- Esophageal Carcinoma
- Breast Cancer
- Lymph Node Dissection
- Immune Checkpoint Blockade
- Clinical Trials
- Precision Medicine
- Molecular Profiling
- Cetuximab
- Prognosis
- Therapeutic Targets
- Surgical Management
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy31▲ 27×21 topics
- Endoscopic Resection17▲ 102×2 topics
- Neoadjuvant Therapy16▲ 42×5 topics
- Clinical Practice Guidelines15▲ 17×10 topics
- Tumor Microenvironment14▲ 20×7 topics
- Epidemiology14▲ 2.1×29 topics
- Molecular Characterization13▲ 46×4 topics
- Prognostic Factors13▲ 19×14 topics
- Survival Analysis12▲ 27×6 topics
- Immunotherapy12▲ 10×15 topics
- Chemoradiation10▲ 98×2 topics
- Preoperative Chemoradiotherapy10▲ 77×2 topics
- Adjuvant Therapy10▲ 47×2 topics
- Radiotherapy10▲ 15×12 topics
- Gastric Cancer10▲ 51×3 topics
- Surgery9▲ 16×4 topics
- Cancer9▲ 4.0×28 topics
- Barrett's Esophagus9▲ 133×1 topic
- Esophageal Carcinoma9▲ 133×1 topic
- Targeted Therapy8▲ 23×4 topics
- Breast Cancer8▲ 21×9 topics
- Neoadjuvant Chemotherapy8▲ 58×2 topics
- Lymph Node Dissection8▲ 81×1 topic
- Metastatic Gastric Cancer8▲ 81×1 topic
- Immune Checkpoint Blockade8▲ 42×1 topic
- PD-1 and PD-L18▲ 42×1 topic
- Clinical Trials7▲ 6.3×5 topics
- Quality of Life7▲ 2.9×14 topics
- Precision Medicine6▲ 8.5×4 topics
- Genetic Mutations6▲ 9.1×11 topics
- Molecular Profiling6▲ 39×3 topics
- Metastasis6▲ 11×9 topics
- Cetuximab6▲ 40×2 topics
- Rituximab6▲ 22×3 topics
- Prognosis5▲ 10×6 topics
- PET Imaging5▲ 19×4 topics
- Therapeutic Targets5▲ 21×5 topics
- Molecular Subtypes5▲ 37×3 topics
- Surgical Management5▲ 7.4×9 topics
- Prognostic Markers5▲ 28×3 topics
Which research topics does Saitama Cancer Center publish most on?
By volume in 2022–2025: Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers and Colorectal Cancer Treatments and Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Esophageal Cancer Research and Treatment Surgery 9 works
- 2 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 8 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 4 Colorectal Cancer Treatments and Studies Oncology 4 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 6 Cancer Genomics and Diagnostics Cancer Research 3 works
- 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 8 Pancreatic and Hepatic Oncology Research Oncology 3 works
- 9 Genetic factors in colorectal cancer Pathology and Forensic Medicine 3 works
- 10 Chronic Lymphocytic Leukemia Research Genetics 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Saitama Cancer Center's research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Saitama
- Saitama University
- National Defense Medical College
- Dokkyo University
- Josai University
- Social Insurance Saitama Chuo Hospital
- Saitama International Medical Center
- Meikai University
- Saitama Prefecture
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.